Sign in / Join Now
ETFs & Funds
BioTime Sets Its Sights On The Medical-Aesthetics Market $
Add a reply...
Latest StockTalks »
people get BTX breaking news and analysis by email alert.
Get email alerts on BTX »
Get latest price
From other sites
Ladenburg Initiates BioTime Shares With Buy, $6 Price Target
at Benzinga (Fri, 8:59AM)
BioTime To Webcast Presentation At The Ladenburg Thalmann 2016 Healthcare Conference
at TheStreet (Fri, 7:00AM)
BioTime – The Next Biotech Tenbagger ?
at TalkMarkets (Tue, 10:00PM)
BioTime Affiliate, Asterias Biotherapeutics, Announced Positive Interim Efficacy Data From Trial In Patients With Complete Cervical Spinal Cord Injuries
at TheStreet (Sep 15, 2016)
BioTime Announces Issuance Of 31 New Patents To Strengthen Its Patent Portfolio In Regenerative Medicine
at TheStreet (Aug 15, 2016)